Greg Tourangeau - Net Worth and Insider Trading
Greg Tourangeau Net Worth
The estimated net worth of Greg Tourangeau is at least $37,490 dollars as of 2024-11-05. Greg Tourangeau is the Principal Accounting Officer of Fulcrum Therapeutics Inc and owns about 11,571 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $37,490. Details can be seen in Greg Tourangeau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Greg Tourangeau has not made any transactions after 2024-05-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Greg Tourangeau
Greg Tourangeau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greg Tourangeau owns 1 companies in total, including Fulcrum Therapeutics Inc (FULC) .
Click here to see the complete history of Greg Tourangeau’s form 4 insider trades.
Insider Ownership Summary of Greg Tourangeau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2024-05-07 | Controller |
Greg Tourangeau Latest Holdings Summary
Greg Tourangeau currently owns a total of 1 stock. Greg Tourangeau owns 11,571 shares of Fulcrum Therapeutics Inc (FULC) as of May 7, 2024, with a value of $37,490.
Latest Holdings of Greg Tourangeau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2024-05-07 | 11,571 | 3.24 | 37,490 |
Holding Weightings of Greg Tourangeau
Greg Tourangeau Form 4 Trading Tracker
According to the SEC Form 4 filings, Greg Tourangeau has made a total of 3 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 236 shares on May 7, 2024, which brought Greg Tourangeau around $1,831.
Insider Trading History of Greg Tourangeau
- 1
Greg Tourangeau Trading Performance
Greg Tourangeau Ownership Network
Ownership Network List of Greg Tourangeau
Ownership Network Relation of Greg Tourangeau
Greg Tourangeau Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Greg Tourangeau is the Controller of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include director & See Remarks Alex Sapir , Chief Financial Officer Alan A Musso , and 10 percent owner Ra Capital Healthcare Fund Lp .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Greg Tourangeau made 3 insider transaction in Fulcrum Therapeutics Inc (FULC) with a net sale of 5,330. Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 43,360 shares made by Alex Sapir ,
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Greg Tourangeau Mailing Address
Above is the net worth, insider trading, and ownership report for Greg Tourangeau. You might contact Greg Tourangeau via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
